Burning Rock Biotech Limited (BNR) Financials
BNR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 160.0 million | 41.6 million |
2023-06-30 | 183.7 million | 50.1 million |
2023-03-31 | 231.4 million | 62.5 million |
2022-12-31 | 205.7 million | 54.0 million |
BNR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.5 million | ? |
2023-06-30 | -10.9 million | 5.2 million |
2023-03-31 | -18.9 million | 47.6 million |
2022-12-31 | -16.4 million | 11.3 million |
BNR Net Income
No data available :(
BNR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | - | - | 2.6 million |
2023-06-30 | 101.1 million | - | 4.2 million |
2023-03-31 | 132.0 million | - | 6.0 million |
2022-12-31 | 115.2 million | - | 7.4 million |
BNR Shares Outstanding
BNR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 11.5 million | 24.8 million | - |
2023-06-30 | - | 13.2 million | 9.6 million | 9.8 million |
2023-03-31 | 9.0 million | 14.7 million | 19.3 million | 12.4 million |
2022-12-31 | 9.0 million | 13.7 million | 18.6 million | 9.4 million |
BNR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 17.5 million | 5.7 million |
2023-06-30 | 20.2 million | 6.3 million |
2023-03-31 | 20.7 million | 6.0 million |
2022-12-31 | 20.7 million | 6.3 million |
BNR
Price: $0.81
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -0.88
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 139800
Market Capitalization: 73.4 million